CoChat

Expansion of circulating Foxp3+CD25bright CD4+ T cells during specific venom immunotherapy

Pereira‐Santos, M. C., Baptista, A. P., Melo, A., Alves, R. R., Soares, R. S., Pedro, E., Pereira‐Barbosa, M., Victorino, R. M. M., Sousa, A. E. · 2008 · Clinical & Experimental Allergy
Cited by 69

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Summary: Background Venom immunotherapy (VIT) induces long‐lasting immune tolerance to hymenoptera venom antigens, but the underlying mechanisms are not yet clarified. Regulatory T cells are thought to play an important role in allergic diseases and tolerance induction during specific immunotherapy. Aim Characterize longitudinally the impact of VIT on the pool of circulating regulatory T cells. Methods Fourteen hymenoptera venom‐allergic patients with severe reactions (grades III–IV) were studied before, 6 and 12 months after starting ultra‐rush VIT. Freshly isolated peripheral blood mononuclear cells were surface stained with a panel of markers of T cell differentiation and intracellularly for CTLA‐4 and Foxp3 and analysed by flow cytometry. foxp3 mRNA was quantified by real‐time PCR. VIT responses were assessed by measuring specific IgG4 and IgE levels. Eleven individuals with no history of insect venom allergy were studied as controls. Results VIT induces a significant progressive increase in both the proportion and the absolute numbers of regulatory T cells defined as CD25 bright and/or Foxp3+ CD4+ T cells. These changes are not related to alterations in the expression of activation markers or imbalances in the naïve/memory T cell compartments. foxp3 mRNA levels also increased significantly during VIT. Of note, the increase in circulating regulatory T cell counts significantly correlates with the venom‐specific IgG4/IgE ratio shift. Conclusion VIT is associated with a progressive expansion of circulating regulatory T cells, supporting a role for these cells in tolerance induction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2222.2007.02887.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 69

Metadata

Authors
Pereira‐Santos, M. C., Baptista, A. P., Melo, A., Alves, R. R., Soares, R. S., Pedro, E., Pereira‐Barbosa, M., Victorino, R. M. M., & Sousa, A. E.
Venue
Clinical & Experimental Allergy
Publisher
Wiley
Published
2007-12-07
Volume
38
Issue
2
Pages
291-297
ISSN
  • 0954-7894 (ISSN-L)
  • 1365-2222
OpenAlex
W1647951943
Cited by
69
References
2
FWCI
5.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expansion of circulating Foxp3+CD25bright CD4+ T cells during specific venom immunotherapy. https://app.cochat.ai/papers/10.1111/j.1365-2222.2007.02887.x
The paper
Pereira‐Santos, M. C., Baptista, A. P., Melo, A., Alves, R. R., Soares, R. S., Pedro, E., Pereira‐Barbosa, M., Victorino, R. M. M., & Sousa, A. E. (2008). Expansion of circulating Foxp3+CD25bright CD4+ T cells during specific venom immunotherapy. Clinical & Experimental Allergy. https://doi.org/10.1111/j.1365-2222.2007.02887.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.